Medication info
Metformin 500 mg Tablets (Metformin Hydrochloride)

Metformin 500 mg Tablets (Metformin Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Ixsu Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201903857 · Approved 2019.06.13 · Insurance code 658502150

Summary

Main use
Treatment of type 2 diabetes mellitus
Who uses it
Adults · Children
Adult dosage
Adults The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses daily with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and identify the minimum effective dose. Measure glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient previously controlled with diet alone, a short course of this medicine may provide sufficient effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.
Children's dosage
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 doses.

Ingredients

Manufacturer
Ixsu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used for the treatment of patients with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise. It is particularly effective in overweight adult patients and may be used alone or in combination with other oral hypoglycemic agents or insulin. It may also be used in children over 10 years of age and adolescents in growth either as monotherapy or in combination with insulin. This medication effectively controls blood sugar and assists in diabetes management.

Dosage and Administration

Adult dosage

Adults The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses daily with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and identify the minimum effective dose. Measure glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient previously controlled with diet alone, a short course of this medicine may provide sufficient effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.

Children's dosage

Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is advised. It should not be administered to patients with moderate or severe renal impairment, acute heart failure, serious infections, or dehydration. The administration of this medication should be discontinued before and after examinations using radiological iodine contrast agents, and it should be resumed only after confirming kidney function. It is not to be used in patients with a history of hypersensitivity to this medication, type 1 diabetes, or diabetic ketoacidosis. After severe infections or major trauma, and before and after surgery, this medication may need to be temporarily discontinued and can be resumed when the patient's condition stabilizes. Caution is also required for patients with liver dysfunction, severe lung disease, or excessive alcohol consumption. This medication can cause a rare but serious side effect called lactic acidosis, so if symptoms such as fatigue, myalgia, shortness of breath, or abdominal pain occur, a doctor should be consulted immediately. Gastrointestinal side effects may commonly occur but are usually transient and can be minimized by administering the medication with meals. Blood sugar control levels should be regularly checked, and kidney function and hematological tests should be performed periodically. Alcohol consumption may increase the risk of side effects of this medication, so patients should avoid excessive drinking. Elderly patients or those with reduced kidney function require careful dosage adjustment and regular monitoring. There may be interactions with other medications, so patients should inform their physician or pharmacist of any other medications they are taking. During pregnancy, it may affect the fetus, so it should be used according to a doctor's instructions if necessary. While nursing, there is a concern that this medication may pass into breast milk and affect the newborn, so careful consideration should be given to breastfeeding and medication use. Special caution is advised for children and adolescents, and it should be administered in accordance with the indications for use. In cases of overdose, blood dialysis can be used to remove the drug, so if overdose is suspected, immediate medical attention should be sought. This medication does not cause weight gain, making it advantageous for diabetic patients who need weight management. Regular blood sugar testing and body condition checks, as well as consistent consultation with healthcare professionals, are important for the safe use of this medication.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormality
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help preserve the medication's efficacy and safety for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.